首页 | 本学科首页   官方微博 | 高级检索  
     


Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial
Authors:Thomas P Leist  Giancarlo Comi  Bruce A C Cree  Patricia K Coyle  Mark S Freedman  Hans-Peter Hartung  Patrick Vermersch  Florence Casset-Semanaz  Matthew Scaramozza
Affiliation:1. Thomas Jefferson University, Philadelphia, PA, USA;2. Department of Neurology and Institute of Experimental Neurology, University Vita-Salute IRCCS, San Raffaele Hospital, Milan, Italy;3. University of California, San Francisco, CA, USA;4. Stony Brook University Medical Center, Stony Brook, NY, USA;5. University of Ottawa and the Ottawa Hospital Research Institute, Ottawa, ON, Canada;6. Department of Neurology and Center for Neuropsychiatry, Medical Faculty, Heinrich-Heine University, Duesseldorf, Germany;7. University of Lille-Nord de France, Hôpital Roger Salengro, Lille, France
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号